newsfilter
← Latest News
ACCESS Newswire·

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patient trials, is now in the grid game,